Cargando…
Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
OBJECTIVES: Hypertension is well established as a major risk factor for cardiovascular disease. Although there is undeniable evidence to support the beneficial effects of antihypertensive therapy on morbidity and mortality, adequate blood pressure management still remains suboptimal. Research into t...
Autores principales: | Fares, Hassan, DiNicolantonio, James J, O'Keefe, James H, Lavie, Carl J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051471/ https://www.ncbi.nlm.nih.gov/pubmed/27752334 http://dx.doi.org/10.1136/openhrt-2016-000473 |
Ejemplares similares
-
β-Blockers in hypertension, diabetes, heart failure and acute
myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Capsaicin may have important potential for promoting vascular and metabolic health
por: McCarty, Mark F, et al.
Publicado: (2015) -
The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease
por: DiNicolantonio, James J, et al.
Publicado: (2014) -
Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa
por: O'Keefe, James H, et al.
Publicado: (2016) -
Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)